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Introduction: Of those people who survive a stroke, only between 40 and 70% regain
upper limb dexterity. A number of reviews have suggested that functional electrical
stimulation (FES) may have a beneficial effect on upper limb motor recovery. In light
of the promise offered by FES and the limitations with current systems a new system
was developed (FES-UPP) to support people with stroke (PwS) to practice a range of
voluntary controlled, FES-assisted functional activities.
Objective: This paper reports on a three center clinical investigation with the primary aim
of demonstrating compliance of the new FES systemwith relevant essential requirements
of the EU Medical Device Directive, namely to evaluate whether use of the FES-UPP
enables PwS to perform a wider range of functional activities, and/or perform the same
activities in an improved way.
Design: Clinical investigation and feasibility study.
Settings: An in-patient stroke unit, a combined Early Supported Discharge (ESD) and
community service, and an outpatient clinic and in-patient stroke unit.
Participants: Nine therapists and 22 PwS with an impaired upper limb.
Intervention: Every PwS was offered up to eight sessions of FES-UPP therapy, each
lasting ∼1 h, over a period of up to 6 weeks.
Primary and secondary outcome measures: The operation, acceptability, and
feasibility of the interventions were assessed using video rating and the Wolf Motor
Function Test Functional Ability Scale (WMF-FAS), direct observations of sessions and
questionnaires for therapists and PwS.
Results: The system enabled 24% (Rater A) and 28% (Rater B) of PwS to carry out a
wider range of functional tasks and improved the way in which the tasks were performed
(mean scores of 2.6 and 2.2 (with FES) vs. mean scores 1.5 and 1.3 (without FES)
(p < 0.05).
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Conclusion: The FES-UP proved feasible to use in three different clinical environments,
with PwS who varied widely in their impairment levels and time since stroke. Therapists
and therapy assistants from a wide range of backgrounds, with varying degrees
of computer and/or FES knowledge, were able to use the system without on-site
technical support.
Keywords: functional electrical stimulation, upper limb, stroke, rehabilitation, clinical investigation, usability,
functional activity
INTRODUCTION
It is estimated that each year more than 100,000 stroke cases
occur in the UK [The (1)]. Although the incidence of stroke
has been slowly declining, acute treatments and hence survival
rates have been improving significantly and the numbers living
with stroke in the UK are increasing (2). Of those who survive a
stroke only between 40 and 70% regain dexterity, depending on
the initial severity of stroke (3). The ability to reach, grasp and
manipulate objects is essential for independent accomplishment
of daily tasks (4) and regaining upper limb function is a priority
for people with stroke (PwS). Upper limb deficits have a direct
effect on the ability to participate in functional and social aspects
of life, which in turn influences quality of life (5).
A number of studies (6–8) have shown that high intensity,
activity specific practice, supported by appropriate technology,
can have a significant positive impact on upper limb motor
recovery following stroke. However, although current clinical
practice in treating people early after stroke varies between
centers and across countries, it is generally characterized by low,
or very low doses of activity-specific practice (9, 10) and limited
use of suitable technology (11). Technology-based interventions
not only offer the possibility of delivering high doses of functional
activity practice without equivalent staffing demands, they also
offer certain functionality not possible with traditional manual
therapy approaches (12). Of key relevance to this study, unlike
traditional therapy approaches, functional electrical stimulation
(FES) directly activates lower motor neurons and associated
sensory systems, which in turn has been shown to have effects
on cortical activity (13). Further, appropriately delivered FES
uniquely offers the opportunity for activity-specific practice using
only the subject’s own (impaired) neuromuscular system, rather
than with assistance from a therapist, or a robotic device.
A number of reviews have suggested that FES may have
a beneficial effect on upper limb motor recovery, if delivered
in an appropriate way to the right patients, particularly early
after stroke (14, 15). Electrical stimulation also has the potential
to offset muscle decline associated with aging (16). Evidence
from a recent study suggested that the therapeutic effect seen
following a period of FES use is seen only in patients who retain
the ability to produce brain activation patterns associated with
movement planning (17) suggesting that an association of FES-
induced movement with planned movement may be key to FES-
supported recovery. Many previous devices have greatly limited
the opportunity for the voluntary engagement with functional
tasks which evidence suggests may be pivotal to recovery (17, 18).
However, the devices used in many of the upper limb FES
studies included in recent reviews typically stimulate only a small
number of muscles, and offered little or no flexibility in how the
FES was controlled.
In light of the promise offered by FES and the limitations with
current systems we have developed a new FES system which will
support patients to practice a range of voluntary controlled, FES-
assisted upper limb functional activities. The new system, FES-
UPP, described in detail in Sun et al. (19), allows therapists to set
up sequenced patterns of electrical stimulation, bespoke to the
particular activity being practiced, and patient’s pattern of upper
limb impairment.
This paper reports on a three center clinical investigation
designed with the primary aim of demonstrating compliance of
the new FES system with relevant essential requirements of the
EU Medical Device Directive (20). Specifically, the primary aims
of the study were to:
1) “Verify that, under normal conditions of use, the performance
characteristics of the device are those intended by the
manufacturer” (Essential Requirement 3). Normal conditions
of use referred to therapist supervised use in a range of
different clinical settings. For this study we used the term
“therapist” to cover the range of professionals trained and
deployed in the UK NHS to support, in a variety of ways,
upper limb recovery in stroke.
Performance characteristics intended by the manufacturer
in this investigation were that use of the FES-UPP enabled
participants to perform a wider range of FES supported
functional activities, and/or perform the same activities in an
improved way (19).
2) Determine any undesirable side effects and assess whether
these constitute risks when weighed against the intended
performance of the device (Essential Requirement 6).
Secondary aims were to gather data to inform future
efficacy studies (recruitment rates, and reasons for (non)-
recruitment, patient characteristics, and the feasibility of the
outcome measures) and to evaluate the system’s usability
(observed and reported errors and other usability issues from
both the patient and therapist perspectives, together with
setup times).
METHODS
Study Participants
We aimed to recruit nine therapists and thirty PwS across the
three sites. Site X: An in-patient stroke unit; Site Y: A combined
Early Supported Discharge (ESD) and community service; Site Z:
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An outpatient clinic and in-patient stroke unit. All participants
provided informed written consent to participate in the study.
Therapists were recruited if they worked with stroke patients
and had successfully completed the training to use FES-UPP. In
order to test the range of patient participant presentations the
new FES-UPP device could be used with, we sought to recruit
a heterogeneous group. Eligibility criteria for people with stroke
were as follows:
Inclusion Criteria
Aged 16 or over; evidence of a clinical stroke; impairment
of one or both upper limbs, for which they are, or plan to
be, participating in therapy; medically fit to engage in active
therapy sessions; sufficient level of cognition and communication
to comply with the assessments and participate in the study;
participant expected to remain under the care of one of the
services for sufficient time to allow at least two sessions with
FES-UPP to be completed.
Exclusion Criteria
Any neurological condition that affects voluntary control of
upper limb movements; complex regional pain syndrome;
orthopedic conditions that restrict joint range; severe
Rheumatoid Arthritis; epilepsy not adequately controlled by
medication; cardiac pacemaker or other active implanted device;
metal external fixator implant; cancerous tissue/malignancy in
the region of stimulation; pregnancy; skin rash, allergy, broken
skin, wound, or poor skin condition in an area where electrodes
are to be placed; requiring an interpreter.
A number of criteria were flagged as needing to be discussed
with the Research Team before recruitment occurred:
Painful shoulder, or pain in the upper limb; participating in
another study; fixed flexion contracture or excessive spasticity in
more than two muscles; any medical condition other than those
listed above that may affect the response to ES.
Overview of FES-UPP System
The FES-UPP system design is described in detail in Sun et al.
(19) and shown in Figure 1.
FIGURE 1 | The FES-UPP system (the model in this figure has provided
written informed consent to publish this photograph).
In brief, the system consists of a dedicated tablet computer,
a Graphical User Interface (GUI), using which the therapist
sets up the FES controller, a five channel stimulator
with electrodes and associated cables, up to four inertial
measurement units with associated cables, an instrumented
object which provides input to the controller, and a manual
push button.
The tablet based setup software guides therapists through
setting up the system. The setup process consists of five stages:
1) Selection and modification of activities from the FES-UPP
upper limb activity library which contained 17 functional
activities, and/or creation of new activities. The components
of the FES-UPP activity library are provided in Table 1. Stage
1 guides the therapist in creating, modifying and selecting
functional activities for the patient. Each activity is defined
as a sequence of movement phases and their associated set of
muscle(s) to be stimulated.
2) Donning of electrodes and sensors and set up of channels.
In stage 2, the therapist is required to associate stimulation
channels with the muscles chosen in Stage 1, to check that the
placement of each electrode produces the right response, to
set maximum and motor threshold for each channel, and to
decide on the set of sensors to be used. If body-worn inertial
measurements are to be used, the therapist also assigns the
sensor(s) to appropriate body segment(s).
3) Set up of stimulation parameters for each movement phase
for each of the selected activities. In this stage of setup, the
therapist is required to set up suitable stimulation profiles for
each muscle in each phase for each of the selected activities.
A stimulation profile consists of a delay (s), ramp time (s)
and target intensity value (µs). The device frequency was set
at 40Hz. Once the therapist is satisfied that the stimulation
profiles are acceptable, the whole activity can be attempted
by the patient, with the therapist moving between movement
phases by pushing a button. During each ES-assisted attempt
at the activity that the therapist decides is satisfactory, data
from any of the assigned sensors, together with time-since-
entering the phase is logged by the software, for use in stage 4.
4) Set up of transition rules. Once the therapist is satisfied with
the stimulation profiles for each muscle in each phase, stage 4
involves defining the transition rules for progressing from one
phase to the next. A transition between two successive phases
can be triggered by a button press, a timeout, a change in body
segment angle since entering the phase, instrumented object
functions, or a logical combination of two of these events.
Data collected during stage 3 is used to guide the therapist in
this process.
5) Set up of patient instructions and biofeedback. In this stage
the therapist sets up patient and activity-specific instructions
and feedback on performance during practice of the activities.
After completing the five setup stages, the therapist can
leave this part of the software and enter the “Session
Manager,” which allows the PwS to practice the chosen
functional activity(s), and provides feedback to the
therapist and PwS on their performance, both during and
after practice.
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TABLE 1 | Components of the FES-UPP activity library.
Activity category Name of activity
A. Simple movements • Pendular shoulder exercises (with
scapula stabilization)
B. Unilateral activities
i. With scapula stabilization • Reaching forwards to target
• Sweeping coins
• Wash face with sponge
• Dusting away from body
ii. Without scapula stabilization • Sweeping coins
• Dusting across body
• Wash unaffected arm
• Picking up mobile phone
• Drink from beaker
• Eat using spoon
• Place object on shelf
C. Asynchronous bimanual activities
• Hold and open jar
• Pour from bottle into glass
• Cut up food
D. Synchronous bimanual activities
i) With scapula stabilization • Sit to stand using arm support
ii) Without scapula stabilization • Place tray on shelf
Study Design
The study design was based on a body of evidence supporting
the value of intensive [(21), task-specific, electrical stimulation
assisted (ES) (15)], voluntary initiated (17) practice in either
speeding up, or improving recovery of upper limb function (22).
The focus of our study was to demonstrate that the FES-UPP
system could be used in clinical settings to deliver task-specific,
high intensity, voluntary initiated, ES-assisted task practice.
Patient Recruitment
All potential participants were provided with a Patient
Participant Information Sheet and Patient Participant Invitation
Letter explaining the purpose and content of the study. In
cases where the potential participant was judged to have
communication difficulties, the recruiting team used an
alternative, adapted Patient Participant Information Sheet and
consent form, developed with the help of a specialist Aphasia
group. Potential participants were given as much time as they
require to consider the information, with a minimum of 24 h. All
participants provided informed written consent to participate in
the study.
FES-UPP Sessions
Each center was provided with three FES-UPP systems. A
clinician manual and on-line training resource accompanied
the system to supplement the clinician training, and provide
instructions on using the FES-UPP.
Every PwS was offered up to eight sessions of therapy using
the FES-UPP system, each lasting ∼1 h, over a period of up
to 6 weeks. The frequency and duration of therapy sessions
was informed by the project advisory group, which included
therapists and PwS. In order to conform to standard care there
was no set schedule for when sessions should happen. Instead
FIGURE 2 | Saebo MAS de-weighting system. Clinical media reproduced with
permission from SaeboUK Ltd and consent to publish https://www.saebo.
com/media/.
therapists were encouraged to use the systemwith each patient, as
appropriate, for up to eight sessions. The operation, acceptability,
and feasibility of the interventions were assessed using video
rating as the primary outcome measure, direct observations of
sessions and questionnaires for therapists and PwS.
The therapist and PwS agreed on one or more activities
to be practiced using the FES-UPP system. Activities were
selected based on clinical assessment and were such that they
were difficult, or impossible for the PwS to perform unaided.
The therapist set up the sequenced patterns of stimulation
to multiple muscles to support the PwS in performing each
of the functional activities, and where appropriate so that
the system provided appropriate feedback and/or instruction.
The PwS was encouraged to practice, under supervision, each
of the FES-supported activities, until they indicated a desire
to stop, or the session outcomes had been achieved. Center
X piloted the use of the FES-UPP system in combination
with an upper limb de-weighting system (Figure 2), for
PwS who required additional assistance to move their arm
against gravity.
Capture of the Primary Outcome Data
The primary outcome data was collected in a separate session
to the standard FES-UPP treatment sessions (Figure 3A). The
purpose was to address the primary research aim of verifying the
performance characteristics, specifically that use of the FES-UPP
enables PwS to perform a wider range of functional activities;
and/or perform the same activities in an improved way. During
one of the sessions the researcher video recorded each attempt
at each activity for later analysis. Where possible, this session
took place in the second or third treatment session to avoid the
risk of discharge before the outcome measure could be taken.
Session 1 was avoided to allow all participants to familiarize
themselves with the system. In addition to the PwS and the
treating therapist, a member of the research team was also
present. The researcher, therapist and PwS agreed on up to two
suitable unilateral activities, one or both of which may have been
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FIGURE 3 | (A,B) Flow diagrams of the data collection protocols for both the PwS and therapists.
used in a previous session. As this type of session was to evaluate
the performance of the system, and in order to reduce the effects
of inter-therapist skill variability in using the system, the study
researchers advised where necessary on the optimum setup of
the FES-UPP system. The setup was fine-tuned to allow a robust
attempt at the activity suitable for recording. The software was
used to set all stimulation levels in each phase to zero and the
PwS was asked to attempt the activity unaided (without FES). The
FES stimulation levels were then re-instated the PwS was asked to
attempt the activity with FES support. The process was repeated
for a second activity where possible.
Members of the local research team were responsible
for identifying adverse or serious adverse events. The local
investigator was responsible for documenting the event and
contacting the Principle Investigator to decide on the most
appropriate course of action.
Enrolment, Follow-Up, and Analysis
The local research team at each site screened PwS for eligibility
to enter the study. A full set of enrolment data was only available
from Centers X and Y. A summary of the data for enrolment,
follow-up and analysis is provided in the Consort flow diagram
in the results section (Figure 4).
Study Outcome Measures and Analysis
The study outcome measures are summarized below and
categorized in accordance with the aims of the study.
Primary Aim 1: Demonstration of Compliance With
Relevant ER of EU Medical Devices Directive
(a) To assess the primary outcome of the study i.e., to evaluate
whether use of the FES-UPP enables PwS to perform a wider
range of functional activities, and/or perform the same activities
in an improved way, video recordings from FES-UPP outcome
data collection sessions were taken of up to 2 functional
tasks (1 or 2 tasks whichever was feasible for the PwS). An
adapted version of the scoring system used in the Wolf Motor
Function Test Functional Ability Scale (WMF-FAS) (23) was
used (Table 2). Two rater’s blinded to the condition (i.e., with,
or without FES), evaluated randomized video footage of each
activity using the six point ordinal WMF-FAS on two separate
occasions. Paired blinded observations of performance on up
to two upper limb activities (with FES-UPP compared with the
patient’s unaffected arm vs. without FES-UPP, again compared
with their unaffected arm) were made for each PwS. In order to
identify consistency of rating across the two rater’s, inter-rater,
and intra-rater reliability analysis was carried out. In order to
determine the consistency of ratings, the two rater’s conducted
two separate ratings of the video footage within 1 week.
To evaluate whether use of FES-UPP enables participants to
perform activities in an improved way, paired observations of
performance on up to two upper limb activities (with vs. without
FES-UPP) were made for each PwS. A Wilcoxon Signed-Ranks
test was used to test for differences in performance with vs.
without FES-UPP (p< 0.05).
To test whether FES-UPP enabled participants to perform
a wider range of activities, each of the WMF-FAS scores were
reduced to categorical data. If an attempt scored a 0 or 1, the
attempt was deemed to be a failure. If an attempt scored 2–6, the
attempt was deemed a success. TheMcNemar test was used to test
for differences in number of activities achieved with vs. without
FES-UPP (p< 0.05).
Primary Aim 2: To Determine Any Undesirable Side
Effects and Assess Whether These Constitute Risks
When Weighed Against the Intended Performance of
the Device
A record of adverse events was documented using a standard
study designed proforma.
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FIGURE 4 | A CONSORT flow diagram showing patient enrolment, follow-up, and analysis at Centers X and Y.
Secondary Aims
1) To gather data to inform future efficacy studies
Recruitment rates and reasons for non-recruitment were
recorded at each site. Descriptive statistics were used to
summarize the key findings.
To record the characteristics of PwS, a profile assessment form
was completed within the first week (Table 2) to record date of
birth, contact details, GP, date of stroke, side affected, dominant
hand, spasticity measured using the Modified Ashworth Scale
(24), upper limb impairments measured using the Fugl-Meyer
upper extremity scale (25), neglect measured using the Star
Cancellation Test (26), and cognitive ability measured using the
Montreal Cognitive Assessment (27).
In order to characterize the therapist participant’s their
professional role, grade, level of experience in clinical practice,
pre-study experience with FES and amount & type of computer
use were recorded using the therapist profiling questionnaire.
The FES-UPP software logged the information during
each therapy session onto the tablet in real time (28). The
information logged by the software summarized the patient setup
information, events that occurred in the FES-UPP software and
information corresponding to each repetition of activity. The
patient setup information contained the core setup information,
including Finite State Machine (FSM) parameters (e.g., number
of phases, phase name(s), muscles to be stimulated during each
phase), stimulation parameters that defined stimulation profiles
(pulse width, ramp time, delay time, and motor threshold),
and transition rules etc. Events that occurred in the FES-UPP
software were timestamped and logged when the user logged
into and out of the software, entered different setup stages
or when practicing within the session manager. Information
corresponding to each repetition of activity included the number
of repetitions, time spent in each movement phase, reason(s)
for leaving each movement phase, and whether a successful
repetition was achieved. A successful repetition was deemed
to have occurred when the FSM had progressed through each
movement phase and returned to the neutral phase.
The amount and type of therapy delivered, number of
sessions, number of repetitions, activity type, practice time, and
setup time per participant was recorded. Setup time was defined
as the time taken for the therapist to progress through stages 1 to
5 of the setup process. Setup time was compared with practice
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TABLE 2 | An adapted version of the Wolf Motor Function Test Functional Ability
Scale (WMF-FAS).
0 = Does not attempt with upper extremity (UE) being tested (no movement in
spite of attempt)
1 = UE being tested does not participate functionally; however, an attempt is
made to use the UE (Guidance notes: some movement present, not functional)
2 = Does, but requires more than two attempts to complete, or accomplishes
very slowly (Guidance notes: accomplishing task, very slowly, gross effort)
3 = Does, but movement is influenced to some degree by synergy or is
performed slowly or with effort (Guidance notes: slow, moderate effortful with
synergy)
4 = Does; movement is close to normal* but slightly slower; may lack precision,
fine coordination, or fluidity (Guidance notes: minimal effort)
5 = Does; movement appears to be normal*
The guidance notes are intended to provide additional instructions to rater’s to aid clarity.
*For the determination of normal, the less-involved UE can be utilized as an available index
for comparison, with premorbid UE dominance taken into consideration.
time and degree of upper limb impairment. Type of activities
chosen for each of the three sites and has been reported in a
previous paper (19).
2) Usability
To evaluate the usability of the FES-UPP from the therapist’s
perspective, therapists were asked to complete a short form at the
end of each session. Members of the research team also observed
sessions where they recorded the details of any usability issues on
a study designed usability form (Figure 3A).
To evaluate the usability of the FES-UPP from the PwS
perspective we asked them to complete a short questionnaire
(aided by the therapist) at the end of their time in the study (See
Figure 3B and Supplementary Figure 1). Four respondents had
communication difficulties, resulting in an adapted version of the
questionnaire being used e.g., a numeric Likert scale and pictures
to assist with answering the questions. This was developed with
input from a specialist aphasia group.
Data Analysis
Participant characteristics (PwS and therapists) and frequency of
use of the FES-UPP system by therapists were analyzed using
descriptive statistics.
The videos of participants attempting activities with and
without FES were analyzed as follows. First, the quality of each
video was assessed one of the study researchers determine if
it was suitable for subsequent analysis. For the set of videos
identified, inter-rater agreement on the quality of upper limb
movement (WMF-FAS) was assessed using a weighted Kappa. In
order to determine the consistency between rater’s in assessing
the quality of movement for the upper limb during a functional
task, the WMF-FAS scores for all patients (with and without
FES combined) were compared between rater’s using a weighted
Kappa (κw) with linear weights (29). This was calculated twice,
because each rater scored the videos on two occasions.
Kappa values were interpreted as follows: below 0.0 poor,
0.0–0.20 slight, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80
substantial, 0.81–1.00 almost perfect (30).
To test whether FES-UPP allowed PwS to perform the same
activities in an improved way, a Wilcoxon signed-rank test
was used to test for differences in WMF-FAS with or without
the FES-UPP.
To test whether the FES-UPP system enabled participants to
perform a wider range of activities, each of the WMF-FAS scores
were reduced to categorical data. If an attempt scored a 0 or 1,
the attempt was deemed to be a failure. If an attempt scored 2–6,
the attempt was deemed a success. An exact McNemar’s test was
used to test for differences in number of activities achieved with
vs. without FES-UPP (p< 0.05).
The quantitative questionnaire data (Likert scale) were
analyzed using descriptive summary statistics. The open-
ended questions provided qualitative data that were grouped
into themes.
Usability feedback from the therapist collected from
observations of them using the system was analyzed using
descriptive statistics to identify the key usability issues in each
stage of the setup process. Setup time data was collected using the
FES-UPP therapy session data logging system (28). Mean setup
times were calculated for each center. The relationship between
mean setup times and upper limb impairment was analyzed
using correlation methods. All statistical analysis was completed
using SPSS v24 (p< 0.05).
RESULTS
Recruitment
Only screening data from Centers X and Y were available. Across
these centers, 193 PwSwere screened of which 171 were excluded.
One hundred and twenty eight were ineligible, reasons being
not a CVA (TIA or dementia) (n = 21), no, or resolved upper
limb weakness (n = 31), severe cognitive impairment (n = 25)
discharged from hospital (n= 22), medically unfit (n= 8), other
conditions (n = 6), required an interpreter (n = 5), more than
6 months post stroke (n = 4), fixed contractures/spasticity (n =
4), uncontrolled epilepsy (n = 2) Very few patients declined to
participate (n = 3), and 40 did not take part for other reasons
(Figure 4).
Patients who met the inclusion criteria (n = 22) were
consented into the study. One patient declined treatment after
giving consent due to personal circumstances and was therefore
withdrawn from the study, and any subsequent data analysis.
Study Participant Characteristics
Table 3 summarizes the characteristics for the 22 PwS who were
recruited into the study. We successfully implemented the study
in three centers with different stroke populations. As the data
for Center Z was taken from an in-patient stroke unit and an
out-patient clinic, the data was categorized into acute/sub-acute
(<6 months) and chronic (>6 months). The median age of PwS
was 67 (IQR 55.5–78.75). Age was similar across Centers X, ,Y
and the in-patient facility at Center Z, and older at the out-
patient clinic, with a median age of 73 (IQR 54.75–77.75). There
were almost twice as many male participants than female, 71%
were right hand dominant. As expected the participants at Site
X (the acute/sub-acute stroke center) were very early post-stroke
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TABLE 3 | Descriptive statistics for PwS study participants (median, IQR for age in years, gender, hand dominance, time since CVA (weeks), side of stroke and Fugl-Myer
UE score) (FMA-UE).
Description Center X
(n = 7)
Center Y
(n = 4)
Center Z Totals across all centers
(n = 21)
Acute/sub-acute
(n = 5)
Chronic
(n = 6)
Age
(years)
Mean 63
(±20.94)
Mean 63
(±20.94)
Mean 65.2
(±14.98)
Mean 66.66
(±15.62)
Mean 65.47
(±14.58)
Median 60 Median 67 Median 61 Median 73 Median 67
IQR 52.5-81.5 IQR 65.75-68.5 IQR 60-78 IQR 54.75-77.75 IQR 55.5-78.75
Gender 6M (86%) 2M (50%) 1M (25%) 5M (83%) 14M (64%)
1F (14%) 2F (50%) 4F (75%) 1F (17%) 8F (36%)
Hand dominance 5R (71%) 4R (100%) 5R (100%) 6R (100%) 20R (91%)
2L (29%) 2L (9%)
Affected side 4R (57%) 1R (25%) 3R (60%) 2R (33%) 10R (45%)
3L (43%) 3L (75%) 2L (40%) 4L (67%) 12L (55%)
FMA-UE/66 Median 8 Median 10.5 Median 4 Median 10 Median 8
IQR 5-11 IQR 7.25-18.25 IQR 4-4 IQR 7.75-10.75 IQR 4.25-11.75
Time since CVA
(weeks)
Median 0.78 Median 22 Median 6 Median 134 Median 7
IQR 1-1.5 IQR 17.5-23.75 IQR 3-7 IQR 79-252 IQR 2-47
TABLE 4 | Professional role, grade, level of experience in clinical practice, pre-study experience with FES and amount & type of computer use.
Therapist
ID
Role & grade Clinical experience Previous FES experience Computer use
Patients
treated
Length
(years)
Use of
FES
Type of FES UL/LL Frequency Frequency Type
XOT1 OT Band 7 Stroke 15 N - - - D C/SD/PR/BW
XPT1 PT Static Band 6 Stroke 6 Y MD LL OC D C/SD/PR/BW
XRA1 Therapy assistant Stroke 1 N - D C/PR/WP
YOT1 OT Band 6 Comm
Stroke/ESD
7 N - - - M WP
YPT1 PT Band 7 Comm
Stroke/ESD
16 N - - - D C/SD/PR/BW
YPI1 Stroke Specialist
Nurse/Coordinator
Stroke 12 N - - - M C
YRA1 Assistant Practitioner Stroke 10 N - - - D C/SD/BW/PR
YRA2 Technical Instructor Stroke 1 N - - - D C/SD/BW/PR/WP
ZPT1 Lead Physio/Clinical
Tutor
Stroke/MS/ABI/SCI 21 Y Exercise stimulator
Odstock Pace
UL/LL D D C/BW/SD
ZCE l Clinical Engineer Stroke/MS/TBI/SCI 5 Y Exercise
stimulatorODFS Pace
LL M D C/SD/BW
ZCE2 Clinical Engineer Stroke/MS/TBI/SCI 30 Y Exercise stimulator,
Odstock Pace
UL/LL D D C/SD/BW/PR/WP
Mean= 11.27
(±8.83)
X, Y & Z in the therapist ID depicts the center. Key to abbreviations provided below.
BW, browsing web; C, communication; D, daily; F, fortnightly; M, monthly; MD, missing data; N, no; N/A, not applicable; O, once only; OC, occasionally; OT, Occupational therapist; PG,
playing games; PR, patient records; PT, Physiotherapist; RA, Rehabilitation Assistant; S, spread sheets; SI, social interaction; SD, searching databases; W, weekly; WP, word processing,
Y, yes.
(range 1–3 weeks). Center Y (ESD & community) predominantly
recruited from the community service rather than the ESD
service, resulting in a median time since stroke of 22 weeks. The
median length of time since stroke among outpatients at Site Z
was much higher, 134 weeks. Side of stroke was similar across all
centers. Upper limb impairment, measured using the Fugl-Myer
upper extremity scale, had a median level of 8, indicating severe
impairment, and was lowest (median 4) in the acute/sub-acute
stroke ward, Center Z.
Eleven therapists were recruited across the three centers,
comprising three Physiotherapists, two Occupational therapists,
one Nurse, three Therapy Assistants, and two Clinical Engineers.
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Their mean clinical experience of treating PwS was 11.27 years.
Four of the treating therapists had previous experience of using
FES (Table 4).
A total number of 123 FES-UPP sessions were administered
across the three centers (Table 5). Center Z carried out the most
FES-UPP sessions (n = 3 therapists, 65 sessions), followed by
Center X (n = 3 therapists, 43 sessions) with Center Y (n = 5
therapists, 15 sessions) using the FES-UPP system the least. At
Center Y the physiotherapist and nurse did not use the system.
The highest ranked frequency of setup for the FES-UPP was the
Therapy Assistant at Center X (XTA1= 39), the clinical engineers
at Center Z (n = 27 and 25), followed by the Occupational
Therapist (n = 14), and Therapy Assistant 1 (YTA1 = 6) at
Center Y.
TABLE 5 | Total number of FES-UPP sessions per therapist, PwS across all study sites.
Patient
ID
Therapist ID Total no. of
sessions/patient
XOT
1
XPT
1
XTA
1
YOT
1
YPT
1
YPI
1
YTA
1
YTA
2
ZPT
1
ZCE
1
ZCE 2
X01 3 5 5(5S) 5
X02 3 3(1S) 7(7S) 8
X03 1(1S) 5 7(6S) 7
X04 0 2 3(3S) 3
X05 4 1 8(5S) 8
X06 1 6(1S) 5(5S) 6
X07 2 2(2S) 4(4S) 6
Total no. sessions 43 (±1.77)
Y01 5(3S) 0 0 2(2S) 0 5
Y02 2(2S) 0 0 1(1S) 1 3
Y03 4(1S) 0 0 3(S) 0 4
Y04 3(3S) 0 0 0 0 3
Total no. sessions 15 (±0.95)
Z01 0 8(8S) 3 8
Z02 0 0 8(8S) 8
Z03 8(8S) 0 0 8
Z04 0 8(8S) 0 8
Z05 0 0 1(1S) 1
Z06 0 4(4S) 0 4
Z07 0 0 8(8S) 8
Z08 0 0 7(7S) 7
Z09 0 1(1S) 0 1
Z10 8(8S) 0 0 8
Z11 0 4(4S) 0 4
Total no. sessions 65 (± 2.87)
Total no. sessions /
therapist
14
(1S)
24
(4S)
39
(37S)
14
(9S)
0
(0S)
0
(0S)
6
(6S)
1
(0S)
16
(16S)
25
(25S)
27
(24S)
Total no.
sessions = 123
(± 25.05)
CE, Clinical Engineer; OT, Occupational Therapist; PT, physiotherapist; PI, Nurse; SU, setup of FES-UPP.
TABLE 6 | Descriptive primary outcome data and Wilcoxon-signed rank test result for Rater’s A and B.
Test Rater A (n = 25) Rater B (n = 25)
↑ = ↓ Mean
WMF-FAS
(with FES)
Mean WMF-FAS
(without FES)
p-value ↑ = ↓ Mean
WMF-FAS
(with FES)
Mean WMF-FAS
(without FES)
Difference
(%) p-value
Wilcoxon-signed
rank test
17 (68%) 6 (24%) 2 (8%) 2.6 1.5 p < 0.05 16 (64%) 7 (28%) 2 (8%) 2.2 1.3 p < 0.05
↑, improved; = no difference; ↓, did not improve.
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Primary Outcome Measure Results
Demonstration of Compliance With Relevant ER of
EU Medical Devices Directive
One hundred videos were identified as being of suitable quality to
be taken forward for analysis for (25 without FES and 25 with FES
(n = 50), for each of the two rater’s (n = 100). The video footage
was analyzed by the same rater’s on two occasions = total of 200
videos rated).
There was substantial agreement between the two rater’s on
both occasions (30): the first round of rating results were κw =
0.665 (95% CI, 0.533–0.797), p < 0.05 and the second round κw
= 0.667 (95% CI, 0.533–0.807), p< 0.05. As the second round of
rating was marginally more consistent for the two rater’s, it was
used for the Wilcoxon signed-rank test statistical analysis.
In order to assess the primary outcome of the study, whether
using FES-UPP enabled PwS to perform the same activities in
an improved way, fifty video clips of PwS performing functional
tasks with and without FES were rated by two rater’s using
the WMF-FAS. Rater A deemed that 17 (68%) of the video
clips showed improved functional performance with FES-UPP
in situ, 2 (8%) were deemed to not have improved, and 6 (24%)
were unchanged. Rater B rated 16 video clips (64%) as showing
improved functional performance with FES, 2 (8%) as showing
no improvement, and 7 (28%) to be unchanged. For Rater A, the
mean WMF-FAS score when using FES-UPP was 2.6, compared
to 1.5 without FES-UPP, a difference of 1.1, and the difference was
significant (p< 0.05). Rater B scored consistently lower both with
and without FES-UPP, however the overall difference between
conditions was similar: the mean score when using FES-UPP was
2.2, compared to 1.3 without FES-UPP, a difference of 0.9, and
the difference was significant (p< 0.05) (Table 6).
Adverse Incidents
Two serious adverse events occurred during the study. These
were reported to the authorities and sponsor and were deemed
to be unrelated to the procedure or investigational device.
Secondary Outcome Data
Usability Issues, Including Logged Usage Data,
Observed Errors, Quantitative and Qualitative
Feedback on the System, and Setup Time
The logged data showed that the patterns of stimulation used
to support practice of the same activity varied significantly
across participants. As an example, the set of stimulation targets
used by different therapists to support participants to practice
the “Drink from a beaker” activity are shown in Table 7. This
finding supported the utility of our flexible system, in which the
stimulation patterns can be selected based both on the patient’s
presentation and activity requirements.
Trial researchers (n = 3) conducted observations of the set-
up and practice of FES-UPP at all three centers, 15 observations
in total. Each time a problem arose that prevented the therapist
from progressing through the setup process and/or practice
(Session Manager), this was defined as a usability error. Table 8
displays the frequency of usability errors in each stage. Most
errors occurred at Stages 1, 2, and 3.
TABLE 7 | Stimulation targets used by therapists to support participants to
practice the “Drink from a beaker” activity across movement phases.
Participant ID &
muscles stimulated
Stimulation values (µs) across movement phases
Starting
position
Reach Grasp Lift Replace Release
Z03
Extensors 0 146 48 46 56 225
Flexors 0 0 224 176 196 0
Triceps 0 126 76 0 220 0
Biceps 0 0 0 120 0 0
Z04
Anterior deltoid and
triceps
0 122 112 0 132 132
Extensors 0 162 0 42 42 72
Flexors 0 0 182 42 42 0
Biceps 0 0 0 172 0 0
Z06
Abductor pollicis
longus
0 183 0 0 0 122
Extensors 0 0 0 0 0 12
Flexors 0 0 92 102 0 0
Triceps 0 42 42 0 62 0
Biceps 0 0 0 82 0 0
TABLE 8 | Number of usability issues recorded in each stage of the setup
process.
Stage of setup Frequency of
usability errors
Loading patient file 4
Stage 1: Selecting/editing activity 8
Stage 2: Donning electrodes & setting stimulation targets 11
Stage 3: Adjusting stimulation levels across all phases 11
Stage 4: Selecting transition rules 1
Stage 5: Instructions and feedback 3
Session manager 4
Total 42
The frequency of usability errors were analyzed to determine
the main usability problems. In response to therapist, PwS and
researcher feedback a number of changes were suggested for
the FES-UPP system, for example: Stage 1: re-designed to make
selection and modification of library activities more intuitive;
stage 2: anatomical terms to be used to automatically populate
the sensor information; stage 3: allow pulse width to be decreased
without stimulation being on.
A total of 15 (68%) PwS completed a questionnaire. Given
the low number of participants, we have combined strongly
agree/agree and strongly disagree/disagree categories. Nine PwS
(60%) enjoyed using FES-UPP, 8 (53%) found it quick to set
up, none found it uncomfortable. All participants found it easy
to work with the system. Five PwS (33%) did not use the
sensors, however those that did found them comfortable to wear.
Fourteen out of the fifteen participants (93%) would recommend
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the system to other PwS, with the majority (n = 13, 87%) stating
they would continue using the system if it was available.
Of the 15 PwS who were able to provide qualitative feedback,
eight PwS (53%) remarked on the positive experience of seeing
and feeling their arm/hand move again and other health benefits
such as greater relaxation of their limb, and a feeling of increased
energy. Three respondents (20%) suggested that there should
be more emphasis on the hand/fingers, giving more help with
correctly placing the electrodes and for the activities to be of
sufficient duration to promote recovery.
Seven respondents (47%) found the on-screen instructions
easy to understand and use and one asked for more
feedback/graphs on the screen. Two respondents (13%)
only received instructions from their therapist rather than using
the on-screen instructions. The majority of the centers did not
make use of the feedback function, however of those that did one
respondent (7%) wanted more feedback/graphs on screen. Six
people (40%) asked for the system to be easier to setup so they
could apply it independently. Suggestions were use of a glove,
fewer wires and a larger screen, with a take home system seen
as desirable.
The setup time varied across centers (Figure 5). Our earlier
(lab-based) work suggested setup time was positively correlated
with impairment level (31).
There was no correlation between PwS level of impairment
and length of time to setup the FES-UPP system. (r = −0.124,
n= 21, p> 0.05).
DISCUSSION AND LIMITATIONS
Primary Aim of the Study
Demonstration of Compliance With Relevant ER of
EU Medical Devices Directive
The primary aim of the study was to establish whether the FES-
UPP system enabled participants to perform a wider range of
activities and/or enabled participants to perform activities in
an improved way. The system enabled 68% (Rater A) and 64%
(Rater B) of PwS to carry out a wider range of functional tasks
or improved the way in which the tasks were performed (mean
WMF-FAS scores of 2.6 and 2.2 (with FES) vs. mean scores
1.5 and 1.3 (without FES) (Table 6). Of the video clips where
rater’s scored the stroke participants either the same or worse, the
majority had a predominance of hypertonicity. This may suggest
that a future efficacy study may consider restricting inclusion to
those without significant spasticity.
The FES-UPP system allowed practice of upper limb
functional activities within busy acute hospital (n= 12) and out-
patients settings (n= 6), and in participants’ homes (n= 4). Each
setting presents its own challenges, short duration of stay for in-
patient settings and logistical challenges such as finding a suitable
surface to accommodate use of the FES-UPP, identification of
functional objects for practice, and the cold temperature of some
homes. The FES-UPP system proved to be sufficiently flexible
to be used to support each participant. It successfully allowed
stroke participants with a wide range of impairments to achieve
active, functional practice that would not have been possible
without FES.
No serious adverse events that were attributable to the FES-
UPP system were noted demonstrating that the system was safe
to use.
Secondary Aims of the Study
PwS and Therapist Recruitment
The study was successful in recruiting and implementing FES in
a varied stroke population, in terms of clinical settings and time
since stroke, and with a range of different types of therapists.
Although a high number of PwS were screened (n = 193), only
22 out of a target of 30 entered the study (Figure 4). Due to
local differences each center screened in accordance with their
own protocols which were not necessarily comparable. In future
a standardized screening tool would ensure greater consistency
of screening and subsequent recruitment. One of the reasons for
exclusion from the study was an upper limb impairment that
resolved early in the hospital stay. Due to new medical advances
e.g., thrombolysis, a greater proportion of patients achieve some
resolution of their impairments in the acute phase post stroke.
The length of time that patients remain in hospital following a
stroke has significantly decreased over the last decade (32), with
themedian length of stay estimated to be 7 days, resulting in some
patient’s being discharged before interventions can commence.
In our study 11 PwS were deemed to be too high level in their
upper limb recovery process to benefit from the FES-UPP system.
Although people with acute stroke may have the potential to
benefit more from FES-UPP than those at a later stage in their
recovery (15) in common with other studies, including those
studying less complex interventions (33), we found recruitment
from this group to be difficult. For instance, at Center X, we
screened 132 acute patients over 7 months and recruited 7 to
the study.
Therapists were enthusiastic to take part in the study, with 11
from an original target of nine therapists recruited. However, one
of the therapists YPI 02 sustained a broken wrist and was unable
to take part in the remainder of the study. Staffing ratio’s at Center
Y were also affected by a staff bereavement. Therapist’s previous
experience of FES did not appear to influence their use of the
FES-UPP system (Table 4).
Usage and Usability of the FES-UPP
System From the Therapist and PwS
Perspectives
Patient participants’ presentation, working practices, culture and
personnel available to use the FES-UPP varied across centers,
could have influenced how the system was used (Table 5). Center
X utilized an inter-disciplinary approach where physiotherapist
worked alongside occupational therapists and therapy assistants
within the same treatment session. In this center, often the
therapy assistant was nominated to setup the system whilst
the physiotherapist and occupational therapist prescribed the
activity to be practiced, and handled the limb where required.
Generally the therapy assistants in this study used the system
more frequently than qualified therapists. If a similar pattern of
use was found in the future, this may both enhance the therapist
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FIGURE 5 | Mean setup times (mins) across Centers.
assistants’ role and have the potential to reduce treatment
staffing costs.
Of the 17 activities in the FES-UPP activities library, sweeping
coins and drinking from a beaker were the most frequently
chosen activities. Therapists tended to opt to either modify an
existing activity from the FES-UPP library, or create their own
activity. Often the created activity was rather simple, for example
reach to target and hand opening.
It is also worth noting that the study protocol somewhat
constrained the therapists’ use of what is a very flexible system.
For instance, in the first few sessions, the therapists focused on
identifying a suitable activity/activities with which to address
the primary aim. It is likely that therapists would need to
use the system for a more prolonged period and without the
constraints of the protocol described here in order to fully exploit
its potential. Future iterations of the system that increase the
amount of guidance for the user, perhaps with a greater use of
default settings, may help with setup and more effective use.
Direct observation of end users working with rehabilitation
technologies presents many challenges, but the importance of
“context of use” and usability testing in “real world” settings
should not be underestimated. The usability observations in our
study were an effective method of identifying issues that were
problematic for therapists when using the system. Stages 2 and
3 of the setup process were the most complicated and therefore
it was not surprising that it was in these stages that the highest
number of usability issues was observed. Stroke participants were
generally positive about the system with 14 out of 15 respondents
reporting that they would recommend the system to other PwS,
and 13 reporting they would have liked to have used the system
for longer. Some PwS commented on the positive experience of
seeing and feeling their arm/hand move again.
Setup Time
The limited time available for rehabilitation, particularly the
hemiplegic upper limb, is a frequently reported challenge in
current UK health care settings. Our study concurred with these
findings, with therapists reporting insufficient time to dedicate
to the treatment of patients. This situation makes setup time for
devices a critical factor in their adoption (10). Setup times in this
study were variable and remained lengthy, with mean setup times
(mins) of 26.7 at Center X, 38.32 at Center Y, and 65.89 at Center
Z (Figure 5). The longer setup times at Center Z appeared to
be influenced by the higher levels of hypertonicity common in
patients with chronic stroke, suggesting future efficacy studies
of FES-UPP should consider the issue of hypertonicity when
defining inclusion and exclusion criteria. Further, two of the
“therapists” at Center Z were bioengineers, and tended to set up
more complex activities than most of the physiotherapists and
occupational therapists involved in the study. Unlike findings
from our previous work (31), setup time in this study appeared
not to be related to level of impairment. However, our previous
study was conducted under much more controlled conditions,
in a laboratory setting with a single therapist, and undoubtedly
other factors also influence the setup times seen in this study,
conducted in the real clinical environment. It was observed
that there were a number of sessions where therapist did not
progress to the “Session Manager” stage, probably due to either
running out of time, or being content to work with the system in
(partial) setup mode; it is worth noting that from stage 3 of setup
onwards the patient is practicing ES-assisted movements. An
improvement in the level of automation of setup and consequent
reduction in setup times, coupled with further training on
the best approaches to using the system may help to alleviate
this problem.
Limitations
The study design proved very time consuming to implement and
relied on the co-operation of therapists at three busy clinical
sites across England. Recruitment proved difficult and a better
screening tool is needed for future studies; the missing screening
data from site Z suggests better training of clinical staff on the
protocol was needed. The training offered to therapists prior
to the study was adequate, but observations reported in our
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previous paper (19) suggesting that efficiency of setup may
improve with time points, with more prolonged training being
required in future studies. The primary outcome measure had
not previously been used to compare performance of activities
with FES to performance without FES and hence a minor
modification was required.While it was shown to be adequate for
its purpose with substantial agreement between the two rater’s, it
relies on inevitable subjectivity of rater’s. Further, it proved time
consuming to deliver and hence in some cases therapists were
only able to record attempts at one, rather than two activities.
Should a similar comparison be required in future studies, it
would be useful to develop an objective metric based on the
logged data, and possibly instrumented analyses e.g., kinematic
and/or kinetic data.
CONCLUSIONS
Despite the limitations discussed above, the study demonstrated
that under normal conditions of use, the performance
characteristics of the device were those intended by the
manufacturer. Specifically, when using FES-UPP, patient
participants were able to perform functional activities in an
improved way and/or performed a wider range of functional
activities than when attempting the same activities without
FES support. The two serious adverse events observed in the
investigation were unrelated to the intervention. The study also
demonstrated the feasibility of using FES-UPP in three different
clinical environments, with patient participants varying widely
in their impairment levels (4–49 on the FM-UE scale) and
time since stroke (1–936 weeks). Further, the results showed
that therapists from a wide range of backgrounds, with varying
degrees of computer and/or FES knowledge, were able to use the
system without on-site technical support. Full patient screening
data were gathered at two out of the three sites and recruitment
data collected at all three sites. It was clear from these that
the key barriers to patient recruitment were no or resolved
upper limb weakness, a high level of cognitive impairment,
or discharged from the service. Therapist recruitment was
straightforward, although retention was a particular problem
at one site, likely due to circumstances beyond our control.
The outcome measures proved feasible to collect, as did the
usability data. Direct observation of therapists/patients coupled
with the data logged by the system, and post-study interview
provided a depth of insight not usually reported in studies of
this type of technology. Overall the system was viewed positively
by PwS. Future studies should investigate whether the FES-UPP
system’s demonstrated capability to support patients to practice
ES-supported functional activities leads to improvements in
unassisted upper limb function.
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